Efficacy of a Gluten-Free Diet in Subjects With Irritable Bowel Syndrome-Diarrhea Unaware of Their HLA-DQ2/8 Genotype

Clinical Gastroenterology and Hepatology

Volumn 14, Issue 5, 2016, Pages 696-703.e1

  Aziz, Imran ^a   Trott, Nick ^a   Briggs, Rebecca ^a   North, John R ^a   Hadjivassiliou, Marios ^a   Sanders, David S ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Carbohydrates; Clinical Trial; Food; Gastrointestinal Symptoms

Indexed keywords

HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; HLA DQ ANTIGEN;

ABDOMINAL DISTENSION; ADULT; ANXIETY; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CLINICAL FEATURE; DEPRESSION; DIARRHEA; FATIGUE; FEMALE; GENOTYPE; GLUTEN FREE DIET; HUMAN; IRRITABLE COLON; MALE; THERAPY EFFECT; CLINICAL TRIAL; GENETICS; IRRITABLE BOWEL SYNDROME; MIDDLE AGED; PROSPECTIVE STUDY; QUESTIONNAIRE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; UNITED KINGDOM;

ADULT; DIARRHEA; DIET, GLUTEN-FREE; FEMALE; GENOTYPE; HLA-DQ ANTIGENS; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES; TREATMENT OUTCOME; UNITED KINGDOM;

EID: 84961218826     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2015.12.031     Document Type: Article

References (33)

1. Chey W.D., Kurlander J., Eswaran S. Irritable bowel syndrome: a clinical review. JAMA 2015, 313:949-958.
2. Lin S., Mooney P.D., Kurien M., et al. Prevalence, investigational pathways and diagnostic outcomes in differing irritable bowel syndrome subtypes. Eur J Gastroenterol Hepatol 2014, 26:1176-1180.
3. Lazaraki G., Chatzimavroudis G., Katsinelos P. Recent advances in pharmacological treatment of irritable bowel syndrome. World J Gastroenterol 2014, 20:8867-8885.
4. Simrén M. Diet as a therapy for irritable bowel syndrome: progress at last. Gastroenterology 2014, 146:10-12.
5. Böhn L., Störsrud S., Törnblom H., et al. Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life. Am J Gastroenterol 2013, 108:634-641.
6. Aziz I., Hadjivassiliou M., Sanders D.S. The spectrum of noncoeliac gluten sensitivity. Nat Rev Gastroenterol Hepatol 2015, 12:516-526.
7. Halmos E.P., Power V.A., Shepherd S.J., et al. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology 2014, 146:67-75.e65.
8. Murray K., Wilkinson-Smith V., Hoad C., et al. Differential effects of FODMAPs (fermentable oligo-, di-, mono-saccharides and polyols) on small and large intestinal contents in healthy subjects shown by MRI. Am J Gastroenterol 2014, 109:110-119.
9. Vazquez-Roque M.I., Camilleri M., Carlson P., et al. HLA-DQ genotype is associated with accelerated small bowel transit in patients with diarrhea-predominant irritable bowel syndrome. Eur J Gastroenterol Hepatol 2011, 23:481-487.
10. Vazquez-Roque M.I., Camilleri M., Smyrk T., et al. A controlled trial of gluten-free diet in patients with irritable bowel syndrome-diarrhea: effects on bowel frequency and intestinal function. Gastroenterology 2013, 144:903-911.e903.
11. Wahnschaffe U., Schulzke J.D., Zeitz M., et al. Predictors of clinical response to gluten-free diet in patients diagnosed with diarrhea-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol 2007, 5:844-850. quiz 769.
12. Ford A.C., Chey W.D., Talley N.J., et al. Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analysis. Arch Intern Med 2009, 169:651-658.
13. Aziz I., Mumtaz S., Bholah H., et al. High prevalence of idiopathic bile acid diarrhea among patients with diarrhea-predominant irritable bowel syndrome based on Rome III criteria. Clin Gastroenterol Hepatol 2015, 13:1650-1655.
14. Leeds J.S., Hopper A.D., Sidhu R., et al. Some patients with irritable bowel syndrome may have exocrine pancreatic insufficiency. Clin Gastroenterol Hepatol 2010, 8:433-438.
15. Halpin S.J., Ford A.C. Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol 2012, 107:1474-1482.
16. Murray J.A., Watson T., Clearman B., et al. Effect of a gluten-free diet on gastrointestinal symptoms in celiac disease. Am J Clin Nutr 2004, 79:669-673.
17. Biagi F., Bianchi P.I., Marchese A., et al. A score that verifies adherence to a gluten-free diet: a cross-sectional, multicentre validation in real clinical life. Br J Nutr 2012, 108:1884-1888.
18. Williams E.A., Stimpson J., Wang D., et al. Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study. Aliment Pharmacol Ther 2009, 29:97-103.
19. Ford A.C., Moayyedi P. Meta-analysis: factors affecting placebo response rate in the irritable bowel syndrome. Aliment Pharmacol Ther 2010, 32:144-158.
20. Shahbazkhani B., Sadeghi A., Malekzadeh R., et al. Non-celiac gluten sensitivity has narrowed the spectrum of irritable bowel syndrome: a double-blind randomized placebo-controlled trial. Nutrients 2015, 7:4542-4554.
21. Böhn L., Störsrud S., Liljebo T., et al. Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial. Gastroenterology 2015, 149:1399-1407.
22. Staudacher H.M., Lomer M.C., Anderson J.L., et al. Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr 2012, 142:1510-1518.
23. Halmos E.P., Christophersen C.T., Bird A.R., et al. Diets that differ in their FODMAP content alter the colonic luminal microenvironment. Gut 2015, 64:93-100.
24. De Palma G., Nadal I., Collado M.C., et al. Effects of a gluten-free diet on gut microbiota and immune function in healthy adult human subjects. Br J Nutr 2009, 102:1154-1160.
25. Sanz Y. Effects of a gluten-free diet on gut microbiota and immune function in healthy adult humans. Gut Microbes 2010, 1:135-137.
26. Mujagic Z., Ludidi S., Keszthelyi D., et al. Small intestinal permeability is increased in diarrhoea predominant IBS, while alterations in gastroduodenal permeability in all IBS subtypes are largely attributable to confounders. Aliment Pharmacol Ther 2014, 40:288-297.
27. Fritscher-Ravens A., Schuppan D., Ellrichmann M., et al. Confocal endomicroscopy shows food-associated changes in the intestinal mucosa of patients with irritable bowel syndrome. Gastroenterology 2014, 147:1012-1020.e1014.
28. Verdu E.F., Huang X., Natividad J., et al. Gliadin-dependent neuromuscular and epithelial secretory responses in gluten-sensitive HLA-DQ8 transgenic mice. Am J Physiol Gastrointest Liver Physiol 2008, 294:G217-G225.
29. Peters S.L., Biesiekierski J.R., Yelland G.W., et al. Randomised clinical trial: gluten may cause depression in subjects with non-coeliac gluten sensitivity: an exploratory randomised clinical study. Aliment Pharmacol Ther 2014, 39:1104-1112.
30. Francis C.Y., Morris J., Whorwell P.J. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther 1997, 11:395-402.
31. Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983, 67:361-370.
32. Fisk J.D., Ritvo P.G., Ross L., et al. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis 1994, 18(Suppl 1):S79-S83.
33. Ware J.E., Gandek B. Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. J Clin Epidemiol 1998, 51:903-912.